Provided by Tiger Trade Technology Pte. Ltd.

Rhythm Pharmaceuticals Inc.

98.01
+1.241.28%
Post-market: 98.010.00000.00%16:10 EDT
Volume:918.21K
Turnover:90.69M
Market Cap:6.75B
PE:-31.44
High:100.85
Open:97.69
Low:97.06
Close:96.77
52wk High:122.20
52wk Low:74.50
Shares:68.85M
Float Shares:65.39M
Volume Ratio:1.44
T/O Rate:1.40%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.1172
EPS(LYR):-3.1100
ROE:-117.04%
ROA:-30.96%
PB:65.53
PE(LYR):-31.51

Loading ...

Rhythm Pharmaceuticals (RYTM) Is Down 13.3% After EMA Backs IMCIVREE Label Expansion for Hypothalamic Obesity

Simply Wall St.
·
Mar 30

Analysts Offer Insights on Healthcare Companies: Ocular Therapeutix (OCUL) and Rhythm Pharmaceuticals (RYTM)

TIPRANKS
·
Mar 27

Rhythm Pharmaceuticals rises; CHMP recommends expanding IMCIVREE EU authorization for acquired hypothalamic obesity, EC decision due Q2 2026

Reuters
·
Mar 26

Rhythm Pharmaceuticals Inc: European Commission Decision Anticipated in Q2 of 2026

THOMSON REUTERS
·
Mar 26

Rhythm Pharmaceuticals Receives Positive Chmp Opinion for Imcivree® (Setmelanotide) for the Treatment of Obesity and Control of Hunger in Patients With Acquired Hypothalamic Obesity Due to Hypothalamic Injury or Impairment

THOMSON REUTERS
·
Mar 26

Rhythm Pharmaceuticals Is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
Mar 23

Rhythm Pharmaceuticals price target raised to $105 from $100 at H.C. Wainwright

TIPRANKS
·
Mar 23

Assessing Rhythm Pharmaceuticals (RYTM) Valuation After FDA Approval Expands IMCIVREE’s Obesity Indication

Simply Wall St.
·
Mar 23

Rhythm Pharmaceuticals, Inc. : H.c. Wainwright Raises Target Price to $105 From $100

THOMSON REUTERS
·
Mar 23

Rhythm Pharmaceuticals picks PANTHERx Rare as exclusive US pharmacy partner for IMCIVREE expanded indication

Reuters
·
Mar 21

Rhythm Pharmaceuticals price target raised to $149 from $139 at BofA

TIPRANKS
·
Mar 20

Palatin’s Case Strengthens as Rhythm’s FDA Approval Validates Hypothalamic Obesity Market (PTN)

TIPRANKS
·
Mar 20

BUZZ-U.S. STOCKS ON THE MOVE-Unilever, Janus, Arm Holdings

Reuters
·
Mar 20

Rhythm Pharmaceuticals Is Maintained at Market Outperform by Citizens

Dow Jones
·
Mar 20

BUZZ-U.S. STOCKS ON THE MOVE-Unilever, Gemini Space Station, FedEx

Reuters
·
Mar 20

S&P 500 Futures Decline In Premarket Trading; Super Micro Computer, Royalty Pharma Lag

Dow Jones
·
Mar 20

Wells Fargo Sticks to Its Buy Rating for Rhythm Pharmaceuticals (RYTM)

TIPRANKS
·
Mar 20

Rhythm Pharmaceuticals Inc : Leerink Partners Raises Target Price to $142 From $136

THOMSON REUTERS
·
Mar 20

Rhythm Pharma Shares Gain 7.4% Premarket After FDA Clears Its Treatment for Brain Damage-Related Obesity

THOMSON REUTERS
·
Mar 20

BUZZ-Rhythm Pharma rises after FDA clears therapy for hypothalamic obesity

Reuters
·
Mar 20